Turn Therapeutics
(NASDAQ) TTRX
Turn Therapeutics Financials at a Glance
Market Cap
$203.15M
Revenue (TTM)
$0.00
Net Income (TTM)
-$3.84M
EPS (TTM)
-$0.18
P/E Ratio
-37.53
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$6.91
Volume
113,337.158
Open
$6.82
Price
$6.91
Volume
113,337.158
Open
$6.82
Previous Close
$6.93
Daily Range
$6.16 - $6.98
52-Week Range
$2.57 - $26.50
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$6.91
Volume
113,337.158
Open
$6.82
Previous Close
$6.93
Daily Range
$6.16 - $6.98
52-Week Range
$2.57 - $26.50
Estimated Earnings Date
Sep 2, 2026
TTRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Turn Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Bradley Burnam
Website
turntherapeutics.comHeadquarters
Westlake Village, CA 91362, US
TTRX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-116.83%
Return on Capital
-122.90%
Return on Assets
-20.58%
Earnings Yield
-2.66%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$203.15M
Shares Outstanding
29.79M
Volume
113.34K
Avg. Volume
41.45K
Financials (TTM)
Gross Profit
-$42.29K
Operating Income
-$6.72M
EBITDA
-$3.79M
Operating Cash Flow
-$3.90M
Capital Expenditure
-$10.00
Free Cash Flow
-$3.90M
Cash & ST Invst.
$11.22M
Total Debt
$6.01M
Turn Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$14.45K
N/A
Gross Margin
0.00%
N/A
Market Cap
$203.15M
N/A
Market Cap/Employee
$101.58M
N/A
Employees
2
N/A
Net Income
-$970.97K
-175.9%
EBITDA
-$956.52K
-171.8%
Quarterly Fundamentals
Total Cash
$11.22M
N/A
Total Debt
$6.01M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.96M
N/A
Short Term Debt
$47.80K
N/A
Return on Assets
-20.58%
N/A
Return on Invested Capital
-49.73%
N/A
Free Cash Flow
-$1.63M
N/A
Operating Cash Flow
-$1.63M
N/A